Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David F Smith

Showing results (251-260 of 254) with videos related to

Pageof 26
Sort By:
You have reached the last page of results.This site can display upto 254 results.
Lancet (London, England)|March 27, 2007
The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trialAnthony G Marson, Asya M Al-Kharusi, Muna Alwaidh, et al.
Biorxiv : the Preprint Server for Biology|January 23, 2026
High-resolution promoter interaction analysis implicates genes involved in the activation of Type 3 Innate Lymphoid Cells in autoimmune disease riskValeriya Malysheva, Helen Ray-Jones, Nora Lakes, et al.
Journal of Medical Genetics|March 12, 2024
Diagnosis and management in Rubinstein-Taybi syndrome: first international consensus statementDidier Lacombe, Agnès Bloch-Zupan, Cecilie Bredrup, et al.
The Laryngoscope|January 6, 2021
Systemic Bevacizumab for Treatment of Respiratory Papillomatosis: International Consensus StatementDouglas R Sidell, Karthik Balakrishnan, Simon R Best, et al.
Pageof 26

Showing results (251-260 of 254) with videos related to

Sort By:
Pageof 26
You have reached the last page of results.This site can display upto 254 results.
Lancet (London, England)|March 27, 2007
The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trialAnthony G Marson, Asya M Al-Kharusi, Muna Alwaidh, et al.
Biorxiv : the Preprint Server for Biology|January 23, 2026
High-resolution promoter interaction analysis implicates genes involved in the activation of Type 3 Innate Lymphoid Cells in autoimmune disease riskValeriya Malysheva, Helen Ray-Jones, Nora Lakes, et al.
Journal of Medical Genetics|March 12, 2024
Diagnosis and management in Rubinstein-Taybi syndrome: first international consensus statementDidier Lacombe, Agnès Bloch-Zupan, Cecilie Bredrup, et al.
The Laryngoscope|January 6, 2021
Systemic Bevacizumab for Treatment of Respiratory Papillomatosis: International Consensus StatementDouglas R Sidell, Karthik Balakrishnan, Simon R Best, et al.
Pageof 26